These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8348751)

  • 1. Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.
    Choi-Miura NH; Sakamoto T; Ohtaki S; Nakamura H; Ishizawa S; Takagi Y; Gomi K; Tomita M
    Clin Exp Immunol; 1993 Aug; 93(2):242-7. PubMed ID: 8348751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement.
    Choi-Miura NH; Sakamoto T; Tobe T; Nakano Y; Tomita M
    J Biochem; 1993 Apr; 113(4):484-7. PubMed ID: 8514737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.
    von Eckardstein A; Huang Y; Kastelein JJ; Geisel J; Real JT; Kuivenhoven JA; Miccoli R; Noseda G; Assmann G
    Atherosclerosis; 1998 May; 138(1):25-34. PubMed ID: 9678768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency.
    Walter M; Kerber S; Fechtrup C; Seedorf U; Breithardt G; Assmann G
    Atherosclerosis; 1994 Oct; 110(2):203-8. PubMed ID: 7848370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural properties of lipid-associated apolipoprotein J (clusterin).
    Calero M; Tokuda T; Rostagno A; Kumar A; Zlokovic B; Frangione B; Ghiso J
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):375-83. PubMed ID: 10567218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
    Francis GA; Knopp RH; Oram JF
    J Clin Invest; 1995 Jul; 96(1):78-87. PubMed ID: 7615839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical studies in a patient with a Tangier syndrome.
    Yao JK; Herbert PN; Fredrickson DS; Ellefson RD; Heinen RJ; Forte T; Dyck PJ
    J Neuropathol Exp Neurol; 1978; 37(2):138-54. PubMed ID: 632844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous Tangier disease and cardiovascular disease.
    Serfaty-Lacrosniere C; Civeira F; Lanzberg A; Isaia P; Berg J; Janus ED; Smith MP; Pritchard PH; Frohlich J; Lees RS
    Atherosclerosis; 1994 May; 107(1):85-98. PubMed ID: 7945562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas.
    Schuler-Lüttmann S; Zhu Y; Hoffmann M; März W; Feussner G; Wieland H; Assmann G; von Eckardstein A
    Metabolism; 2000 Jun; 49(6):770-7. PubMed ID: 10877205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis.
    Mackness B; Hunt R; Durrington PN; Mackness MI
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1233-8. PubMed ID: 9261251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
    Bojanovski D; Gregg RE; Brewer HB
    J Biol Chem; 1984 May; 259(10):6049-51. PubMed ID: 6725246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
    Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
    J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic features in Tangier disease and pathogenetic considerations--Part I. Fatty dots and streaks.
    Haust MD
    Eur J Epidemiol; 1992 May; 8 Suppl 1():36-47. PubMed ID: 1380464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?
    Gelissen IC; Hochgrebe T; Wilson MR; Easterbrook-Smith SB; Jessup W; Dean RT; Brown AJ
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):231-7. PubMed ID: 9512484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.